Francisco J. Serrano Hernando
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francisco J. Serrano Hernando has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Pablo Marques de Marino
Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany
2 shared publications - Agustín Ruiz
Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, TX
1 shared publication - Antonio González-Pérez
Centro Español de Investigación Farmacoepidemiológica (CEIFE), Madrid, Spain
1 shared publication - Antonio Grilo
Medicina Interna, Hospital Virgen de Valme
1 shared publication Antonio Martinezizquierdo
1 shared publicationAntonio Martín Conejero
1 shared publication
Latest Publications
- 1 January 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 30, 299-304
Clinical Outcomes after Endovascular Treatment Failure in Patients with Femoropopliteal Occlusive Disease
- 1 January 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 30, 299-304
Clinical Outcomes after Endovascular Treatment Failure in Patients with Femoropopliteal Occlusive Disease
- 17 July 2012
- Vol. 32 (32) , 523-8
¿Está justificado el seguimiento ecográfico de las fístulas arteriovenosas protésicas húmero-axilares para hemodiálisis?
To evaluate through a specific trial on vascular access fistulas (T-VAF), the impact of intensive follow-up controls on the permeability of humero-axillary fistulas (Hax-AVF). Retrospective study. Between January 2005 and December 2009, 108 Hax-AVF were implanted. From June 2007 a T-AVF was established. A preoperative duplex was performed and a follow-up control carried out a month after the intervention and subsequently every 3 months. An analysis was made of the permeability of 57 Hax-AVF carried out between June 2007 and December 2009 (T-AVF Group), in comparison to 51 interventions performed during the previous 30 months (Control Group). No differences in the permeability achieved were found at 12 and 24 months, with a secondary permeability at 12 months of 49% in the T-AVF Group and 52% in the Control Group. The percentage of patients needing to be re-operated was inferior in the T-AVF Group (35%) than in the Control Group (67%) p=0.02. The re-operation per patient average was lower in the T-AVF Group than in the Control Group (0.49 vs. 1.18 p=0.01). The patients of the TAVF Group underwent a lesser number of re-operations for obstruction as opposed to the Control Group (0.42 vs 1.04 p=0.01). In our experience, the intensive follow-up controls did not improve the permeability of the Hax-AVF, although re-operations due to obstruction did diminish. The follow-up of these access fistulas should be clinical based on hemodialysis data, leaving ultrasonographic evaluation for those cases where a malfunction is suspected.
- 17 July 2012
- Vol. 32 (32) , 523-8
¿Está justificado el seguimiento ecográfico de las fístulas arteriovenosas protésicas húmero-axilares para hemodiálisis?
To evaluate through a specific trial on vascular access fistulas (T-VAF), the impact of intensive follow-up controls on the permeability of humero-axillary fistulas (Hax-AVF). Retrospective study. Between January 2005 and December 2009, 108 Hax-AVF were implanted. From June 2007 a T-AVF was established. A preoperative duplex was performed and a follow-up control carried out a month after the intervention and subsequently every 3 months. An analysis was made of the permeability of 57 Hax-AVF carried out between June 2007 and December 2009 (T-AVF Group), in comparison to 51 interventions performed during the previous 30 months (Control Group). No differences in the permeability achieved were found at 12 and 24 months, with a secondary permeability at 12 months of 49% in the T-AVF Group and 52% in the Control Group. The percentage of patients needing to be re-operated was inferior in the T-AVF Group (35%) than in the Control Group (67%) p=0.02. The re-operation per patient average was lower in the T-AVF Group than in the Control Group (0.49 vs. 1.18 p=0.01). The patients of the TAVF Group underwent a lesser number of re-operations for obstruction as opposed to the Control Group (0.42 vs 1.04 p=0.01). In our experience, the intensive follow-up controls did not improve the permeability of the Hax-AVF, although re-operations due to obstruction did diminish. The follow-up of these access fistulas should be clinical based on hemodialysis data, leaving ultrasonographic evaluation for those cases where a malfunction is suspected.
- Open Access
- 1 January 2008
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 7 (1) , 23
Interaction between Calpain-5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.
Obesity is a multifactorial disorder, that is, a disease determined by the combined effect of genes and environment. In this context, polygenic approaches are needed. To investigate the possibility of the existence of a crosstalk between the CALPAIN 10 homologue CALPAIN 5 and nuclear receptors of the peroxisome proliferator-activated receptors family. Cross-sectional, genetic association study and gene-gene interaction analysis. The study sample comprise 1953 individuals, 725 obese (defined as body mass index > or = 30) and 1228 non obese subjects. In the monogenic analysis, only the peroxisome proliferator-activated receptor delta (PPARD) gene was associated with obesity (OR = 1.43 [1.04-1.97], p = 0.027). In addition, we have found a significant interaction between CAPN5 and PPARD genes (p = 0.038) that reduces the risk for obesity in a 55%. Our results suggest that CAPN5 and PPARD gene products may also interact in vivo.
- 1 January 2008
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 7 (1) , 23
Open AccessInteraction between Calpain-5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.
Obesity is a multifactorial disorder, that is, a disease determined by the combined effect of genes and environment. In this context, polygenic approaches are needed. To investigate the possibility of the existence of a crosstalk between the CALPAIN 10 homologue CALPAIN 5 and nuclear receptors of the peroxisome proliferator-activated receptors family. Cross-sectional, genetic association study and gene-gene interaction analysis. The study sample comprise 1953 individuals, 725 obese (defined as body mass index > or = 30) and 1228 non obese subjects. In the monogenic analysis, only the peroxisome proliferator-activated receptor delta (PPARD) gene was associated with obesity (OR = 1.43 [1.04-1.97], p = 0.027). In addition, we have found a significant interaction between CAPN5 and PPARD genes (p = 0.038) that reduces the risk for obesity in a 55%. Our results suggest that CAPN5 and PPARD gene products may also interact in vivo.
- 1 September 2007
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 60 (9) , 969-982
Enfermedad arterial periférica: aspectos fisiopatológicos, clínicos y terapéuticos
- 1 September 2007
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 60 (9) , 969-982
Enfermedad arterial periférica: aspectos fisiopatológicos, clínicos y terapéuticos